Castle Biosciences Inc (CSTL) earnings
Quarterly results of Castle Biosciences Inc as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Castle Biosciences Inc is expected to report around January 12, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended September 30, 2026) Castle Biosciences Inc reported revenue of $102.9M (+23.9% on the same quarter a year earlier) and a net loss of $4.1M.
Diluted earnings per share were -$0.13.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | $102.9M | +23.9% | -$4.1M | -$0.13 |
| Q2 FY2026 | $103.5M | +20.1% | -$2.1M | -$0.07 |
| Q1 FY2026 | $83.7M | -4.9% | -$14.5M | -$0.49 |
| Q4 FY2025 | $87M | +0.8% | -$2.3M | - |
| Q3 FY2025 | $83M | - | -$501K | -$0.02 |
| Q2 FY2025 | $86.2M | - | $4.5M | $0.15 |
| Q1 FY2025 | $88M | - | -$25.8M | -$0.90 |
| Q4 FY2024 | $86.3M | - | $9.6M | - |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report 10-K
- Quarterly results 8-K
When is Castle Biosciences Inc's next earnings date?
Castle Biosciences Inc is expected to report around January 12, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were Castle Biosciences Inc's latest quarterly results?
For Q3 FY2026, which ended September 30, 2026, Castle Biosciences Inc reported revenue of $102.9M and a net loss of $4.1M. The figures come from its filing with the SEC.
Is Castle Biosciences Inc's revenue growing?
Revenue in Q3 FY2026 was $102.9M, up 23.9% from $83M in the same quarter a year earlier.
Get an email when CSTL reports
Follow CSTL and we email you its next results the day they are filed, with the numbers explained.